Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
A.P. Pharma, Inc.
A.P. Pharma Receives Extension for Nasdaq Listing Compliance
June 27th, 2009
A.P. Pharma, Inc. (Nasdaq: APPA), a specialty pharmaceutical company, announced that on May 29, 2009, it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (Nasdaq) granting A.P. Pharma an extension to regain compliance with the minimum $10 million stockholders' equity requirement for continued listing on The Nasdaq Global Market under Nasdaq Marketplace Rule 5450(b)(1)(A). In April 2009, A.P. Pharma announced that it had received a letter from Nasdaq notifying the Company that it was not in compliance with this requirement. Under the terms of this extension, on or before July 16, 2009, A.P. Pharma must furnish to the Securities and...
Source: Law & Health Weekly (2009-06-27)
|
